Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Older age, obesity, hirsutism, and having children increase metabolic risk in women with PCOS.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

Environmental factors affect reproductive traits by altering the SRD5A1 gene.

Both estrogens and androgens are important for health in both males and females.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

These ovarian conditions cause high testosterone levels.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.